Archives for April 6, 2017

← 2017

IP builds for agmatine use in supplements

The US Patent and Trademark Office (USPTO) has granted Gilad&Gilad an additional patent for agmatine for use in dietary supplements, nutraceuticals, and foods. 

Gnosis gets FDA no objection GRAS for non-animal chondroitin

The US Food and Drug Administration (FDA) has issued a letter of no objection for the GRAS (Generally Recognized as Safe) status of Gnosis S.p.A.’s Mythocondro-branded non-animal chondroitin sulfate for use in foods and beverages.